MLC-activating HLA-D determinants: identification, tissue distribution, and significance
Thorsby, E.; Albrechtsen, D.; Hirschberg, H.; Kaakinen, A.; Solheim, B.G.
Transplantation Proceedings 9(1): 393-400
1977
ISSN/ISBN: 0041-1345 PMID: 68575 Document Number: 110465
Document emailed within 1 workday
Related Documents
Mays, D.C.; Rogers, S.L.; Guiler, R.C.; Sharp, D.E.; Hecht, S.G.; Staubus, A.E.; Gerber, N. 1986: Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites Journal of Pharmacology and Experimental Therapeutics 236(2): 364-373Stokić, E.; Dureković-Katona, A.; Ivković-Lazar, T. 1996: The role and significance of sagittal abdominal diameter in the determination of adipose tissue distribution Medicinski Pregled 49(5-6): 217-220
Martin, B.R.; Dewey, W.L.; Harris, L.S.; Beckner, J.S. 1976: 3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs Journal of Pharmacology and Experimental Therapeutics 196(1): 128-144
Castor, C.W. 1973: Connective tissue activation. V. the flux of connective tissue activating peptide during acute inflammation Journal of Laboratory and Clinical Medicine 81(1): 95-104
Ait-Ghezala, G.; Hassan, S.; Tweed, M.; Paris, D.; Crynen, G.; Zakirova, Z.; Crynen, S.; Crawford, F. 2016: Identification of Telomerase-activating Blends from Naturally Occurring Compounds Alternative Therapies in Health and Medicine 22(Suppl 2): 6-14
Valone, F.H. 1988: Identification of platelet-activating factor receptors in P388D1 murine macrophages Journal of Immunology 140(7): 2389-2394
Hattori, S.; Maekawa, M.; Nakamura, S. 1992: Identification of neurofibromatosis type i gene product as an insoluble GTPase-activating protein toward ras p21 Oncogene 7(3): 481-485
Solo'veva, A.D.; Loseva, M.M. 1989: Significance of the activating and deactivating mechanisms of the brain in autonomic regulation Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 89(10): 26-29
Taska, R.J.; Schoolar, J.C. 1973: Peripheral tissue distribution, brain distribution and metabolism of mescaline- 14 C in monkeys Archives Internationales de Pharmacodynamie et de Therapie 202(1): 66-78
Owosina, F.A. 1974: Significance of activating therapy in the rehabilitation of patients with sickle-cell osteoarthropathy Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 20(6): 385-387
Zhuang, Z.; Huang, S.; Kowalak, J.A.; Shi, Y.; Lei, J.; Furuta, M.; Lee, Y.-S.; Lubensky, I.A.; Rodgers, G.P.; Cornelius, A.S.; Weil, R.J.; Teh, B.T.; Vortmeyer, A.O. 2006: From tissue phenotype to proteotype: sensitive protein identification in microdissected tumor tissue International Journal of Oncology 28(1): 103-110
Awasthi, S.; Sharma, R.; Yang, Y.; Singhal, S.S.; Pikula, S.; Bandorowicz-Pikula, J.; Singh, S.V.; Zimniak, P.; Awasthi, Y.C. 2002: Transport functions and physiological significance of 76 kDa Ral-binding GTPase activating protein (RLIP76) Acta Biochimica Polonica 49(4): 855-867
Mizel, S.B.; Rosenstreich, D.L. 1979: Regulation of lymphocyte-activating factor (LAF) production and secretion in P388D1 cells: identification of high molecular weight precursors of LAF Journal of Immunology 122(6): 2173-2179
Kawamura, Y.; Satoh, K.; Takamatsu, S.; Mizuno, S. 1987: A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions Rinsho Byori. Japanese Journal of Clinical Pathology 35(10): 1149-1153
Peng, Q.-l.; Xie, Y.; Zhang, R.-f.; Shu, X.-m.; Wang, G.-c. 2012: The levels and clinical significance of serum B cell activating factor in Chinese patients with polymyositis or dermatomyositis Zhonghua Nei Ke Za Zhi 51(3): 210-213
Kausz, M.; Murai, Z.; Arimura, A.; Köves, K. 1999: Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactive elements in the brain stem of rats studied by immunohistochemistry Neurobiology 7(1): 19-31
Ando, E.; Nokihara, K.; Naruse, S. 1994: Development of pituitary adenylate cyclase activating polypeptides (PACAPs) specific radioimmunoassay systems and distribution of PACAP-like immunoreactivity in guinea pig tissues Biomedical Peptides Proteins and Nucleic Acids: Structure Synthesis and Biological Activity 1(1): 45-50
Nicholas, R.A.; Watt, W.C.; Lazarowski, E.R.; Li, Q.; Harden, K. 1996: Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor Molecular Pharmacology 50(2): 224-229
Bomalaski, J.S.; Fallon, M.; Turner, R.A.; Crooke, S.T.; Meunier, P.C.; Clark, M.A. 1990: Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo Journal of Laboratory and Clinical Medicine 116(6): 814-825
Bouchard, C.; Després, J.P.; Mauriège, P.; Marcotte, M.; Chagnon, M.; Dionne, F.T.; Bélanger, A. 1991: The genes in the constellation of determinants of regional fat distribution International Journal of Obesity 15(Suppl): 9-18